Ward MA, Fang G, Richards KL, Walko CM, Earnshaw SR, Happe LE, Blalock S. Treatment interruption and regimen change in first-generation vs. second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia. JHEOR. 2015 Apr;2(2):181-91.
Davis KL, Gutierrez B, Zyczynski T, Kaye JA. Real-world treatment patterns in men with castration-resistant prostate cancer receiving docetaxel. JHEOR. 2015 Jan 6;2(2):119-30. doi: 10.36469/9894
Samsell B, Moore M, Bertasi G, Spinato S, Bernardello F, Rebaudi A, Sfasciotti GL, Powers R. Are bone allografts safe and effective for today's dental practitioner? Dentistry. 2014 Nov 3;4(9):1000260. doi: 10.4172/2161-1122.1000260